Phase I trial of hepatic arterial infusion (HAI) of floxuridine with modified oxaliplatin, 5-fluorouracil and leucovorin (m-FOLFOX6) in Chinese patients with unresectable liver metastases from colorectal cancer
Crossref DOI link: https://doi.org/10.1007/s00280-014-2585-7
Published Online: 2014-09-13
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Cong
Gu, Yangkui
Zhao, Ming
Yuan, Yunfei
Wang, Fenghua
Wang, Zhiqiang
Li, Wang
Luo, Huiyan
Chen, Cui
Chen, Gong
Ding, Peirong
Wu, Xiaojun
Lu, Zhenhai
Pan, Zhizhong
Xu, Ruihua
He, Youjian
Wan, Desen
Li, Yuhong
Text and Data Mining valid from 2014-09-13